Fig. 9From: Therapeutic potential of berberine in attenuating cholestatic liver injury: insights from a PSC mouse modelSchematic Representation of BBR’s Potential Mechanisms in Alleviating Cholestatic Liver Injury. This diagram illustrates the proposed molecular and cellular mechanisms through which BBR mitigates cholestatic liver injury in a mouse model of sclerosing cholangitis. It visually summarizes the pathways and interactions influenced by BBR treatment, highlighting its multifaceted role in addressing liver disease pathologyBack to article page